125 related articles for article (PubMed ID: 19324279)
21. The therapeutic effect of a novel GAPDH inhibitor in mouse model of breast cancer and efficacy monitoring by molecular imaging.
Zhang YQ; Zhang W; Kong XT; Hai WX; Guo R; Zhang M; Zhang SL; Li B
Cancer Cell Int; 2024 May; 24(1):188. PubMed ID: 38811918
[TBL] [Abstract][Full Text] [Related]
22. Identifying the necrotic zone boundary in tumour spheroids with pair-correlation functions.
Dini S; Binder BJ; Fischer SC; Mattheyer C; Schmitz A; Stelzer EH; Bean NG; Green JE
J R Soc Interface; 2016 Oct; 13(123):. PubMed ID: 27733696
[TBL] [Abstract][Full Text] [Related]
23. First-in-Human Trial of Epichaperome-Targeted PET in Patients with Cancer.
Dunphy MPS; Pressl C; Pillarsetty N; Grkovski M; Modi S; Jhaveri K; Norton L; Beattie BJ; Zanzonico PB; Zatorska D; Taldone T; Ochiana SO; Uddin MM; Burnazi EM; Lyashchenko SK; Hudis CA; Bromberg J; Schöder HM; Fox JJ; Zhang H; Chiosis G; Lewis JS; Larson SM
Clin Cancer Res; 2020 Oct; 26(19):5178-5187. PubMed ID: 32366671
[TBL] [Abstract][Full Text] [Related]
24. Enhancing the therapeutic effects of in vitro targeted radionuclide therapy of 3D multicellular tumor spheroids using the novel stapled MDM2/X-p53 antagonist PM2.
Mortensen ACL; Morin E; Brown CJ; Lane DP; Nestor M
EJNMMI Res; 2020 Apr; 10(1):38. PubMed ID: 32300907
[TBL] [Abstract][Full Text] [Related]
25. Oxygen diffusion in ellipsoidal tumour spheroids.
Grimes DR; Currell FJ
J R Soc Interface; 2018 Aug; 15(145):. PubMed ID: 30111663
[TBL] [Abstract][Full Text] [Related]
26. Exploration and optimisation of structure-activity relationships of new triazole-based C-terminal Hsp90 inhibitors towards in vivo anticancer potency.
Dernovšek J; Zajec Ž; Poje G; Urbančič D; Sturtzel C; Goričan T; Grissenberger S; Ciura K; Woziński M; Gedgaudas M; Zubrienė A; Grdadolnik SG; Mlinarič-Raščan I; Rajić Z; Cotman AE; Zidar N; Distel M; Tomašič T
Biomed Pharmacother; 2024 Jun; 177():116941. PubMed ID: 38889640
[TBL] [Abstract][Full Text] [Related]
27. Towards personalized computational oncology: from spatial models of tumour spheroids, to organoids, to tissues.
Karolak A; Markov DA; McCawley LJ; Rejniak KA
J R Soc Interface; 2018 Jan; 15(138):. PubMed ID: 29367239
[TBL] [Abstract][Full Text] [Related]
28. Quantifying Imaging Agent Binding and Dissociation in 3-D Cancer Spheroid Tissue Culture Using Paired-Agent Principles.
Li C; Rounds CC; Torres VC; He Y; Xu X; Papavasiliou G; Samkoe KS; Brankov JG; Tichauer KM
Ann Biomed Eng; 2024 Jun; 52(6):1625-1637. PubMed ID: 38409434
[TBL] [Abstract][Full Text] [Related]
29. Hybrid computational models of multicellular tumour growth considering glucose metabolism.
Gonçalves IG; García-Aznar JM
Comput Struct Biotechnol J; 2023; 21():1262-1271. PubMed ID: 36814723
[TBL] [Abstract][Full Text] [Related]
30. Three-Dimensional Cell Culture Systems in Radiopharmaceutical Cancer Research.
Doctor A; Seifert V; Ullrich M; Hauser S; Pietzsch J
Cancers (Basel); 2020 Sep; 12(10):. PubMed ID: 32993034
[TBL] [Abstract][Full Text] [Related]
31. Utility of [18 F]FLT-PET to assess treatment response in trastuzumab-resistant and trastuzumab-sensitive HER2-overexpressing human breast cancer xenografts.
Whisenant JG; McIntyre JO; Peterson TE; Kang H; Sánchez V; Manning HC; Arteaga CL; Yankeelov TE
Mol Imaging Biol; 2015 Feb; 17(1):119-28. PubMed ID: 25034624
[TBL] [Abstract][Full Text] [Related]
32. MR-detectable metabolic consequences of mitogen-activated protein kinase kinase (MEK) inhibition.
Lodi A; Woods SM; Ronen SM
NMR Biomed; 2014 Jun; 27(6):700-8. PubMed ID: 24706368
[TBL] [Abstract][Full Text] [Related]
33. Dual functions of autophagy in the response of breast tumor cells to radiation: cytoprotective autophagy with radiation alone and cytotoxic autophagy in radiosensitization by vitamin D 3.
Bristol ML; Di X; Beckman MJ; Wilson EN; Henderson SC; Maiti A; Fan Z; Gewirtz DA
Autophagy; 2012 May; 8(5):739-53. PubMed ID: 22498493
[TBL] [Abstract][Full Text] [Related]
34. Choline metabolism in malignant transformation.
Glunde K; Bhujwalla ZM; Ronen SM
Nat Rev Cancer; 2011 Nov; 11(12):835-48. PubMed ID: 22089420
[TBL] [Abstract][Full Text] [Related]
35. Hyperpolarized 13C MR spectroscopic imaging can be used to monitor Everolimus treatment in vivo in an orthotopic rodent model of glioblastoma.
Chaumeil MM; Ozawa T; Park I; Scott K; James CD; Nelson SJ; Ronen SM
Neuroimage; 2012 Jan; 59(1):193-201. PubMed ID: 21807103
[TBL] [Abstract][Full Text] [Related]
36. 3D tumour models: novel in vitro approaches to cancer studies.
Nyga A; Cheema U; Loizidou M
J Cell Commun Signal; 2011 Aug; 5(3):239-48. PubMed ID: 21499821
[TBL] [Abstract][Full Text] [Related]
37. Development of radiotracers for oncology--the interface with pharmacology.
Sharma R; Aboagye E
Br J Pharmacol; 2011 Aug; 163(8):1565-85. PubMed ID: 21175573
[TBL] [Abstract][Full Text] [Related]
38. 17-allyamino-17-demethoxygeldanamycin treatment results in a magnetic resonance spectroscopy-detectable elevation in choline-containing metabolites associated with increased expression of choline transporter SLC44A1 and phospholipase A2.
Brandes AH; Ward CS; Ronen SM
Breast Cancer Res; 2010; 12(5):R84. PubMed ID: 20946630
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the Hsp90 inhibitor NVP-AUY922 in multicellular tumour spheroids with respect to effects on growth and PET tracer uptake.
Monazzam A; Razifar P; Ide S; Rugaard Jensen M; Josephsson R; Blomqvist C; Langström B; Bergström M
Nucl Med Biol; 2009 Apr; 36(3):335-42. PubMed ID: 19324279
[TBL] [Abstract][Full Text] [Related]
40. Modeling spheroid growth, PET tracer uptake, and treatment effects of the Hsp90 inhibitor NVP-AUY922.
Bergstrom M; Monazzam A; Razifar P; Ide S; Josephsson R; Langstrom B
J Nucl Med; 2008 Jul; 49(7):1204-10. PubMed ID: 18552146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
